Quick View: Venatorx And Menarini Agreement Will Support Global Access To Antibiotic Cefepime-Taniborbactam
Pharmaceuticals / United States / Thu 11 Jan, 2024
The Latest: On January 9 2024, Venatorx and Menarini announced that they had entered into an agreement for the commercialisation of Venatorx’s investigational drug, cefepime-taniborbactam, an antibiotic being developed for the treatment of complicated urinary tract infections (cUTIs). Under the terms of the agreement, Menarini has obtained